Chromium enhances insulin responsiveness via AMPK

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Trivalent chromium (Cr(3+)) is recognized for its role in improving glucose homeostasis.
• Cr(3+) influences glucose transporter GLUT4 regulation and AMP-activated protein kinase (AMPK) activity.
• The precise mechanisms by which Cr(3+) enhances insulin responsiveness and the role of AMPK are not fully understood.

Purpose of the Study:

• To investigate if Cr(3+) protects against hyperinsulinemia-induced insulin resistance in skeletal muscle cells.
• To determine if AMPK mediates the effects of Cr(3+) on GLUT4 and glucose transport.
• To examine the impact of Cr(3+) on plasma membrane cholesterol and actin cytoskeleton integrity.

Main Methods:

• L6 skeletal muscle myotubes were subjected to hyperinsulinemic conditions to induce insulin resistance.
• Cells were treated with chromium picolinate (CrPic) to assess its protective effects.
• AMPK activity was modulated using siRNA to elucidate its role in Cr(3+) action.
• Measurements included membrane cholesterol, filamentous actin (F-actin) levels, GLUT4 translocation, and glucose transport.

Main Results:

• Hyperinsulinemia led to increased membrane cholesterol, F-actin loss, and impaired GLUT4 translocation and glucose transport in L6 myotubes.
• CrPic treatment prevented these abnormalities and restored normal glucose transport function.
• CrPic increased AMPK signaling, but did not affect insulin signaling pathways.
• Depletion of AMPK via siRNA abolished the protective effects of CrPic.

Conclusions:

• Cr(3+) protects skeletal muscle cells against hyperinsulinemia-induced insulin resistance.
• The beneficial effects of Cr(3+) on glucose transport and GLUT4 regulation are mediated by increased AMPK activity.
• This study highlights the potential of Cr(3+) as a therapeutic agent for improving insulin sensitivity.